Radiation Therapy for Palliation of Sarcoma Metastases: A Unique and Uniform Hypofractionation Experience

Table 1

Patient Characteristics.

Pt	Age	Sex	Site	Pathology	Indication of Treatment	DDD	TTLP	TTDP
1	53	F	Chest	LMC	Adjuvant to surgery	13		61
2	78	F	Thigh	Pleomorphic	Adjuvant to surgery	13
3	65	M	Groin	HGSTS	Palliation	13
4	71	M	Pelvis	Myxoid Chondrosarcoma	Palliation	13	266
5	86	F	Calf	Chondrosarcoma	Palliation	13
6	68	F	Pelvis	MFH	Palliation	13		413
7	41	M	Chest and thigh	SS	Palliation	13	196	247
8	59	F	Thigh	Bone LMS	Palliation	16		56
9	44	M	Chest	HGSTS	Palliation	13		180
10	49	M	Thigh	MFH	Adjuvant to surgery	15		48
11	51	F	Foot	HGSTS	Palliation	14
12	50	M	Pelvis	LMS	Palliation	13
13	60	M	Groin	LMS	Adjuvant to surgery	13		90
14	27	M	Pelvis	Ewing	Palliation	13		5
15	51	F	Chest	LMS	Palliation	13	12	12
16	80	F	Calf, groin, axilla	HGSTS	Palliation	13
17	95	M	Thigh	LMS	Adjuvant to surgery	13		270

Key:Pt: Patient; F:Female; M: Male;LMS: Leiomyosarcoma; HGSTS: High Grade Soft Tissue Sarcoma; MFH: Malignant Fibro Hystiocytoma; SS: Synovial Sarcoma; DDD: Duration of dose delivery; TTLP: time to local progression; TTDM: time to distant progression (the latter 3 parameters all measured in days).